Company
Korrobio
Editing a single letter on RNA to repair or form a de novo protein with enhanced functionality.
Also known as Korro Bio, Korro Bio, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Legal name
- Korro Bio, Inc.
- korrobio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Discover, develop, and commercialize a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients with debilitating and life-threatening diseases.
Funding snapshot
- Total raised
- $4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4M2019-05-24
Funding rounds
- Round, 2019
- $4M2019-05-24, SEC form D sold, 1 investor
Loading relationship preview